293 related articles for article (PubMed ID: 38315025)
1. Photochemical inactivation as an alternative method to produce a whole-cell vaccine for uropathogenic
Westcott MM; Morse AE; Troy G; Blevins M; Wierzba T; Sanders JW
Microbiol Spectr; 2024 Mar; 12(3):e0366123. PubMed ID: 38315025
[TBL] [Abstract][Full Text] [Related]
2. Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection.
Forsyth VS; Himpsl SD; Smith SN; Sarkissian CA; Mike LA; Stocki JA; Sintsova A; Alteri CJ; Mobley HLT
mBio; 2020 Apr; 11(2):. PubMed ID: 32345645
[TBL] [Abstract][Full Text] [Related]
3. Characterization of killed but metabolically active uropathogenic Escherichia coli strain as possible vaccine candidate for urinary tract infection.
Jalili Z; Saleh M; Bouzari S; Pooya M
Microb Pathog; 2018 Sep; 122():184-190. PubMed ID: 29935339
[TBL] [Abstract][Full Text] [Related]
4. The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin.
Westcott MM; Blevins M; Wierzba TF; Morse AE; White KR; Sanders LA; Sanders JW
Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630600
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic Assessment of Clinical Escherichia coli Isolates as an Indicator for Uropathogenic Potential.
Shea AE; Frick-Cheng AE; Smith SN; Mobley HLT
mSystems; 2022 Dec; 7(6):e0082722. PubMed ID: 36445110
[TBL] [Abstract][Full Text] [Related]
6. Ferric Citrate Uptake Is a Virulence Factor in Uropathogenic Escherichia coli.
Frick-Cheng AE; Sintsova A; Smith SN; Pirani A; Snitkin ES; Mobley HLT
mBio; 2022 Jun; 13(3):e0103522. PubMed ID: 35546538
[TBL] [Abstract][Full Text] [Related]
7. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
Asadi Karam MR; Habibi M; Bouzari S
Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
[TBL] [Abstract][Full Text] [Related]
8. Adaptation of Arginine Synthesis among Uropathogenic Branches of the Escherichia coli Phylogeny Reveals Adjustment to the Urinary Tract Habitat.
Hibbing ME; Dodson KW; Kalas V; Chen SL; Hultgren SJ
mBio; 2020 Sep; 11(5):. PubMed ID: 32994329
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
Habibi M; Asadi Karam MR; Bouzari S
Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
[TBL] [Abstract][Full Text] [Related]
10. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
[TBL] [Abstract][Full Text] [Related]
11. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
[TBL] [Abstract][Full Text] [Related]
12. Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.
Brumbaugh AR; Smith SN; Mobley HL
Infect Immun; 2013 Sep; 81(9):3309-16. PubMed ID: 23798537
[TBL] [Abstract][Full Text] [Related]
13. Previous Antibiotic Exposure Reshapes the Population Structure of Infecting Uropathogenic Escherichia coli Strains by Selecting for Antibiotic Resistance over Urovirulence.
Ballash GA; Diaz-Campos D; van Balen JC; Mollenkopf DF; Wittum TE
Microbiol Spectr; 2023 Aug; 11(4):e0524222. PubMed ID: 37338386
[TBL] [Abstract][Full Text] [Related]
14. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic
Sawant NV; Chang SS; Pandit KA; Khekare P; Warner WR; Zimmern PE; De Nisco NJ
Microbiol Spectr; 2024 Mar; 12(3):e0271223. PubMed ID: 38240572
[TBL] [Abstract][Full Text] [Related]
15. Uropathogenic Escherichia coli mediated urinary tract infection.
Totsika M; Moriel DG; Idris A; Rogers BA; Wurpel DJ; Phan MD; Paterson DL; Schembri MA
Curr Drug Targets; 2012 Oct; 13(11):1386-99. PubMed ID: 22664092
[TBL] [Abstract][Full Text] [Related]
16. Identification and Characterization of a Phase-Variable Element That Regulates the Autotransporter UpaE in Uropathogenic Escherichia coli.
Battaglioli EJ; Goh KGK; Atruktsang TS; Schwartz K; Schembri MA; Welch RA
mBio; 2018 Aug; 9(4):. PubMed ID: 30087170
[TBL] [Abstract][Full Text] [Related]
17. CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.
Fortney KR; Smith SN; van Rensburg JJ; Brothwell JA; Gardner JJ; Katz BP; Ahsan N; Duerfeldt AS; Mobley HLT; Spinola SM
Microbiol Spectr; 2022 Apr; 10(2):e0243021. PubMed ID: 35297652
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Requirements of Escherichia coli in Intracellular Bacterial Communities during Urinary Tract Infection Pathogenesis.
Conover MS; Hadjifrangiskou M; Palermo JJ; Hibbing ME; Dodson KW; Hultgren SJ
mBio; 2016 Apr; 7(2):e00104-16. PubMed ID: 27073089
[TBL] [Abstract][Full Text] [Related]
19. Uropathogenic
Alfuraiji N; Al-Hamami A; Ibrahim M; Rajab HK; Hussain BW
J Med Life; 2022 May; 15(5):650-654. PubMed ID: 35815089
[TBL] [Abstract][Full Text] [Related]
20. Plant phenolics inhibit focal adhesion kinase and suppress host cell invasion by uropathogenic
Lewis AJ; Richards AC; Mendez AA; Dhakal BK; Jones TA; Sundsbak JL; Eto DS; Rousek AA; Mulvey MA
Infect Immun; 2024 May; 92(5):e0008024. PubMed ID: 38534100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
